Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cardiovascular safety of the class of JAK inhibitors or tocilizumab compared with TNF inhibitors in patients with rheumatoid arthritis: Systematic review and a traditional and Bayesian network meta-analysis of randomized clinical trials.
Pugliesi A, Oliveira DGC, Filho VAS, Machado JO, Pereira AG, Bichuette JCS, Sachetto Z, de Carvalho LSF, Bertolo MB. Pugliesi A, et al. Among authors: de carvalho lsf. Semin Arthritis Rheum. 2024 Dec;69:152563. doi: 10.1016/j.semarthrit.2024.152563. Epub 2024 Oct 2. Semin Arthritis Rheum. 2024. PMID: 39383617 Review.
Comparative effectiveness and cost-effectiveness of cardioprotective glucose-lowering therapies for type 2 diabetes in Brazil: a Bayesian network model.
Nogueira ACC, Barreto J, Moura FA, Luchiari B, Abuhab A, Bonilha I, Nadruz W, Gaziano JM, Gaziano T, de Carvalho LSF, Sposito AC; Brazilian Heart Study Group. Nogueira ACC, et al. Among authors: de carvalho lsf. Health Econ Rev. 2023 Oct 25;13(1):50. doi: 10.1186/s13561-023-00466-3. Health Econ Rev. 2023. PMID: 37878108 Free PMC article.
Compared efficacy of rituximab, abatacept, and tocilizumab in patients with rheumatoid arthritis refractory to methotrexate or TNF inhibitors agents: a systematic review and network meta-analysis.
Pugliesi A, de Oliveira AB, Oliveira AB, Xavier R, da Mota LMH, Bertolo MB, Gonzalez-Gay MA, Citera G, de Carvalho LSF. Pugliesi A, et al. Among authors: de carvalho lsf. Adv Rheumatol. 2023 Jul 6;63(1):30. doi: 10.1186/s42358-023-00298-z. Adv Rheumatol. 2023. PMID: 37415193
Aspirin in primary prevention and the risk of heart failure: a systematic review and meta-analysis of controlled trials.
de Oliveira ABM, Luchiari B, Bonilha I, Barreto J, Nogueira ACC, Ceniccola GD, Polanczyk CA, Sposito AC, de Carvalho LSF. de Oliveira ABM, et al. Among authors: de carvalho lsf. ESC Heart Fail. 2023 Apr;10(2):1488-1491. doi: 10.1002/ehf2.14269. Epub 2022 Dec 26. ESC Heart Fail. 2023. PMID: 36572648 Free PMC article. No abstract available.
Clinical and economic impact of coronary artery bypass graft and percutaneous coronary intervention in young individuals with acute coronary syndromes and multivessel disease: A real-world comparison in a middle-income country.
Alexim GA, Rocha LF, Dobri GP, Rosa Júnior ADS, Reis RTB, Nogueira ACC, Soares AASM, Sposito AC, de Paula AP, de Carvalho LSF. Alexim GA, et al. Among authors: de carvalho lsf. Front Cardiovasc Med. 2022 Nov 10;9:1000260. doi: 10.3389/fcvm.2022.1000260. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36440021 Free PMC article.
28 results